Rheolytic Hydrodynamic Thrombectomy for Percutaneous Treatment of Acutely Occluded Infra-aortic Native Arteries and Bypass Grafts

医学 经皮 外科 截肢 血栓 穿孔 栓塞 导管 栓塞 血管造影 血管成形术 动脉 放射科 冶金 材料科学 冲孔
作者
S Müller-Hülsbeck,Marc Kalinowski,Martin Heller,H Wagner
出处
期刊:Investigative Radiology [Ovid Technologies (Wolters Kluwer)]
卷期号:35 (2): 131-131 被引量:60
标识
DOI:10.1097/00004424-200002000-00007
摘要

Müller-Hülsbeck S, Kalinowski M, Heller M, Wagner HJ. Rheolytic hydrodynamic thrombectomy for percutaneous treatment of acutely occluded infra-aortic native arteries and bypass grafts: Midterm follow-up results. Invest Radiol 2000;35:131–140. RATIONALE AND OBJECTIVES. To evaluate the efficacy of a rheolytic thrombectomy catheter (RTC) for treatment of acutely occluded infra-aortic native arteries and bypass grafts and to determine midterm primary patency, death, and amputation-free survival rates. METHODS. From March 1995 to September 1997, 112 patients with occluded arteries or bypass grafts were primarily treated with RTC at two centers. Thrombus removal was evaluated by two angiographers. RESULTS. More than 75% of the thromboembolic material could be removed with RTC alone. Mean activation time of RTC was 280 ± 163 seconds. Residual mural or organized thrombi (29%) required adjunctive fibrinolytic therapy or aspiration thrombectomy. Remaining stenoses were treated with percutaneous transluminal angioplasty and additional stent implantation. For acute reocclusions, surgical intervention was required. Technical success after the entire procedure was 88.4%. RTC-associated complications included distal embolization, dissection, vessel perforation, and technical failure of RTC. Mean follow-up time was 14.8 months ± 11.5, rates of primary patency, secondary patency, death, and amputation-free survival were 60%, 84%, 16%, and 75% after 2 years, respectively. CONCLUSIONS. RTC is a rapid and efficient technique for mechanical thrombectomy of acutely thrombosed native leg arteries and bypass grafts. Midterm results are comparable to the results of alternative treatment modalities such as Fogarty balloon thromboembolectomy or local fibrinolysis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
伍声痕发布了新的文献求助10
1秒前
1秒前
英吉利25发布了新的文献求助10
1秒前
3秒前
Akim应助金刚小战士采纳,获得10
3秒前
嘻嘻完成签到 ,获得积分10
4秒前
4秒前
5秒前
michen发布了新的文献求助10
6秒前
6秒前
happyou发布了新的文献求助10
6秒前
wx完成签到,获得积分10
6秒前
木头鱼发布了新的文献求助10
6秒前
yull发布了新的文献求助10
7秒前
7秒前
东方烨伟完成签到,获得积分10
8秒前
在德黑兰击剑的椰子完成签到,获得积分10
8秒前
zyy发布了新的文献求助10
9秒前
10秒前
伊尔发布了新的文献求助10
11秒前
11秒前
已经会了发布了新的文献求助30
11秒前
科研通AI6.3应助pinecone采纳,获得10
11秒前
12秒前
13秒前
科研通AI6.1应助张甜采纳,获得10
13秒前
13秒前
慕青应助drtianyunhong采纳,获得10
14秒前
科目三应助伍声痕采纳,获得10
15秒前
龚幻梦发布了新的文献求助10
16秒前
明年CNS见刊啦完成签到,获得积分10
16秒前
zqqq发布了新的文献求助10
17秒前
我是老大应助单纯的晓刚采纳,获得10
18秒前
18秒前
111111111完成签到,获得积分10
18秒前
shmily完成签到,获得积分10
18秒前
香蕉觅云应助嗯qq采纳,获得10
18秒前
王欣蔚发布了新的文献求助10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Propeller Design 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6015549
求助须知:如何正确求助?哪些是违规求助? 7593900
关于积分的说明 16149217
捐赠科研通 5163316
什么是DOI,文献DOI怎么找? 2764332
邀请新用户注册赠送积分活动 1745005
关于科研通互助平台的介绍 1634757